Evidence map›Paper›PMID 36983477›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

A Saprophytic Fungus

Shengyan Qian, Xuebo Zeng, Yixin Qian, Yongzhong Lu, Zhangjiang He, Jichuan Kang

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Two new species ofMycoKeys · 2026
    Article
  2. Two new species ofMycoKeys · 2025
    Article
  3. Article
  4. Additions to the GenusJournal of fungi (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shengyan QianEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China.ORCID 0000-0002-1239-4516
Xuebo ZengEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China.ORCID 0000-0001-8517-0049
Yixin QianEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China.
Yongzhong LuSchool of Food and Pharmaceutical Engineering, Guizhou Institute of Technology, Guiyang 550003, China.
Zhangjiang HeEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China.
Jichuan KangEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China.
Guizhou University · CNGuizhou Institute of Technology · CN

Funding

National Natural Science Foundation of China 31670027National Natural Science Foundation of China 32170019
6 · The paper itself

Abstract

Two new (

Indexed as

cancer multidrug resistanceGlyceroglycolipidsP-glycoproteinreversesecondary metabolitesTubeufia rubra

Identifiers

PMID36983477
PMCPMC10058889
OpenAlexW4322741758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.